Biotech Values

[jbog]

Sun Pharma to acquire Ranbaxy in a
US$ 4 billion landmark transaction

• To create world's 5th largest specialty generic pharma company
• No. 1 pharma company in India with leadership position in 13 specialty
segments
• No. 1 Indian pharma company in the US
• US$ 250 million of revenue and operating synergies by 3rd year post
close
• Daiichi Sankyo to become the second largest shareholder in Sun Pharma